Used in peptide synthesis as a protected building block, particularly in the preparation of constrained peptides where conformational rigidity is desired. The cyclohexane ring introduces steric hindrance and structural stability, making it valuable in drug design for enhancing metabolic stability and binding selectivity. Commonly employed in solid-phase peptide synthesis (SPPS), the Fmoc group allows for mild deprotection conditions, compatible with a wide range of side-chain protecting groups. Its application is prominent in developing peptidomimetics and bioactive molecules targeting receptors and enzymes in pharmaceutical research.